Pharmacoeconomic evaluations of durvalumab as a first-line treatment for extensive-stage small cell lung cancer： a systematic review
LIU Chengyu, QIN Fang, LIU Lulu, ZHANG Cuicui, XIE Ruijie, LIU Daihua
Chinese Journal of Hospital Pharmacy . 2024, (21): 2523 -2528 .  DOI: 10.13286/j.1001-5213.2024.21.14

Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat